INVESTOR’S BUSINESS DAILY
This year, the first two straight-up marijuana stocks joined the New York Stock Exchange and the Nasdaq.
Tilray Inc. announced it has launched an IPO of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission.
Tilray Inc., a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, today
The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.
THE GLOBE AND MAIL
Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.
Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. That's led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.
Tilray Chief Executive Officer Brendan Kennedy discusses Tilray's Portugal expansion with CBC Business News.
THE NEW YORK TIMES
Tilray CEO Brendan Kennedy shared his insights about Canada's history-making effort to legalize and regulate adult-use cannabis.
Discovering that CBD was an undeveloped potential anticonvulsant that might help thousands of children changed the course of my career. I’m now the clinical research director for Tilray, a medical cannabis company that provides patients with access to safe, reliable and consistent products to treat a wide variety of ailments.
THE GLOBE AND MAIL
Despite a Supreme Court of Canada decision that gives sick Canadians the right to use medical cannabis oils, Ottawa is reimbursing the country’s veterans for dried pot only, potentially pushing them to less healthy options of smoking or vaporizing the drug. Mr. Lucas, also head of patient services at Nanaimo-based grower Tilray, recently launched an e-petition sponsored by his local MP, New Democrat Sheila Malcolmson, asking Veterans Affairs to begin covering these extracts.
PBS speaks to neuroscientist Catherine Jacobson, who heads clinical research for Tilray, about how the company is trying to turn cannabis into conventional medicine.
BUSINESS NEWS NETWORK
Tilray, a Canadian cannabis producer, recently announced that it received approval to ship two varieties of liquid capsules to Croatia. Brendan Kennedy, Global President with Tilray says that Europe presents a good growth opportunity for Tilray.
Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia.
Tilray, based in British Columbia and one of the companies licensed by Canada's federal health ministry to produce and distribute medical cannabis, was recently granted an export permit. It's believed to be the first time a North American company has legally exported cannabis to the EU for commercial medical use.